$CAI insider trading

Over the last 12 months, Caris Life Sciences insiders reported 3 buys totaling $1.1M and 2 sales totaling $16.5M across SEC Form 4 filings. 20% of those filings were made under pre-arranged 10b5-1 trading plans.

$1.1M
$16.5M
5
4
20%
Side
$10M$100MJun '26JulAugSep
Spetzler David Baxley
HALBERT JON
Denton John Russel
Power Luke Thomas

All insider trades

Scroll the table sideways for price, value and marks.

Sep 4, 2026Spetzler David Baxley▼ Sale597,212$24.84$14.8M-33.5%
May 15, 2026HALBERT JON▲ Buy68,000$14.56$990K+10.7%
Dec 11, 2025Power Luke Thomas▼ Sale62,250$26.58$1.7M-38.5%
Nov 7, 2025Spetzler David Baxley▲ Buy400$23.85$10K+0.1%
Nov 7, 2025Denton John Russel▲ Buy4,184$24.09$101K+83.7%

Every $CAI filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Caris Life Sciences filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CAI feed.

CAI Insider Trading — Caris Life Sciences Form 4 Buys & Sells | alphai